Skip to Main Content

Paper Details

Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts.
J Am Heart Assoc
7
2022
3-deoxyglucosone hydroimidazolones, Atherosclerosis, CVD, Cardiovascular Events, Participants, carboxymethyl-lysine, cardiovascular disease, diabetes, dicarbonyl, myocardial infarction, participants, stroke
Author NameAffiliation
Alice M ArnoldSchool of Public Health University of Washington Seattle WA.
Kenneth J MukamalDepartment of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School Boston MA.
David S SiscovickThe New York Academy of Medicine New York NY.
Russell P TracyDepartment of Pathology and Laboratory Medicine University of Vermont College of Medicine Burlington VT.
Bruce M PsatyCardiovascular Health Research Unit, Epidemiology and Health Services University of Washington Seattle WA.
Joachim H IxDepartment of Medicine University of California San Diego CA.
Jorge R Kizer
Jorge R KizerDepartment of Medicine University of California San Francisco CA.
Jorge R KizerDepartment of Epidemiology and Biostatistics University of California San Francisco CA.
  • 1 - 9

Datasets